Trulieve Cannabis Corp. (TRLV)
Trulieve Cannabis Corp. (TRLV) from its SEC filings: 2025 revenue $1.2 billion (-0% vs the year before), net margin -10%, free cash flow $228.6 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Medicinal Chemicals & Botanical Products |
| Revenue (2025) | $1.2 billion |
| Revenue growth | -0% |
| Net income | -$116.4 million |
| Net margin | -9.9% |
| Free cash flow | $228.6 million |
| Diluted EPS | $-0.58 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -10% |
| Cash | $325.4 million |
| Long-term debt | $195.8 million |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.